title: Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma.
abstract: MicroRNAs (miRs) have been identified as potent regulators of both normal development and the hallmarks of cancer. Targeting of microRNAs has been shown to have preclinical promise, and select miR-based therapies are now in clinical trials. Ewing Sarcoma is a biologically aggressive pediatric cancer with little change in clinical outcomes despite improved chemotherapeutic regimens. There is a substantial need for new therapies to improve Ewing Sarcoma outcomes and to prevent chemotherapy-related secondary sequelae. Most Ewing Sarcoma tumors are driven by the EWS/Fli-1 fusion oncoprotein, acting as a gain-of-function transcription factor causing dysregulation of a variety of targets, including microRNAs. Our previous studies, and those of others, have identified upregulation of miRs belonging to the related miR-17~92a, miR-106b~25, and miR-106a~363 clusters in Ewing Sarcoma. However, the functional consequences of this have not been characterized, nor has miR blockade been explored as an anti-cancer strategy in Ewing Sarcoma. To simulate a potential therapeutic approach, we examined the effects of blockade of these clusters, and their component miRs. Using colony formation as a read-out, we find that blockade of selected individual cluster component miRs, using specific inhibitors, has little or no effect. Combinatorial inhibition using miR "sponge" methodology, on the other hand, is inhibitory to colony formation, with blockade of whole clusters generally more effective than blockade of miR families. We show that a miR-blocking sponge directed against the poorly characterized miR-106a~363 cluster is a particularly potent inhibitor of clonogenic growth in a subset of Ewing Sarcoma cell lines. We further identify upregulation of miR-15a as a downstream mechanism contributing to the miR-106a~363 sponge growth-inhibitory effect. Taken together, our studies provide support for a pro-oncogenic role of the miR-106a~363 cluster in Ewing Sarcoma, and identify miR-106a~363 blockade, as well as miR-15a replacement, as possible strategies for inhibition of Ewing Sarcoma growth.
authors: Cancer Biology Graduate Program, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States of America.
authors: Layne
authors: L
authors: Dylla
authors: Paul
authors: P
authors: Jedlicka
mesh_terms: D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002999:Clone Cells; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000378:metabolism; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D012512:Sarcoma, Ewing / Q000235:genetics* / Q000473:pathology*; D015854:Up-Regulation / Q000235:genetics
chemical_list: C542541:MIRN106 microRNA, human; C574861:MIRN363 microRNA, human; D035683:MicroRNAs
references: Oncogene. 2011 Mar 24;30(12):1481-8
references: 21102518
references: Cancer Cell. 2012 Jun 12;21(6):807-21
references: 22698405
references: Expert Rev Anticancer Ther. 2009 Aug;9(8):1025-30
references: 19671021
references: J Pathol. 2012 Apr;226(5):796-805
references: 21960059
references: Oncogene. 2007 Sep 6;26(41):6099-105
references: 17384677
references: Mol Carcinog. 2013 Aug;52(8):634-46
references: 22431000
references: Nature. 2005 Jun 9;435(7043):839-43
references: 15944709
references: J Pediatr Hematol Oncol. 2008 Jun;30(6):425-30
references: 18525458
references: Annu Rev Biochem. 2010;79:351-79
references: 20533884
references: Nat Cell Biol. 2012 Sep;14(9):958-65
references: 22864477
references: Cell Biol Int. 2012 Aug 1;36(8):765-70
references: 22574716
references: Toxicol Sci. 2011 Jan;119(1):50-60
references: 20889678
references: Cancer Res. 2007 Jun 15;67(12):5699-707
references: 17575136
references: J Mol Med (Berl). 2007 Sep;85(9):1015-29
references: 17453169
references: Cell Oncol (Dordr). 2012 Aug;35(4):285-91
references: 22684875
references: Mol Cancer Res. 2011 Apr;9(4):440-7
references: 21454377
references: Gastroenterology. 2009 May;136(5):1689-700
references: 19422085
references: RNA. 2009 Aug;15(8):1443-61
references: 19561119
references: Nature. 2011 Oct 19;478(7369):404-7
references: 22012398
references: Cancer Res. 2008 Oct 15;68(20):8191-4
references: 18922889
references: PLoS One. 2011;6(6):e20781
references: 21698185
references: J Clin Oncol. 1998 Apr;16(4):1248-55
references: 9552022
references: J Biol Chem. 2011 Dec 23;286(51):44095-44103
references: 22049078
references: Cancer. 2011 Nov 1;117(21):4966-76
references: 21480204
references: Sci Signal. 2010 Apr 13;3(117):ra29
references: 20388916
references: FASEB J. 2009 Nov;23(11):3957-66
references: 19608627
references: RNA. 2010 Nov;16(11):2043-50
references: 20855538
references: J Cell Biol. 2012 Oct 29;199(3):407-12
references: 23109665
references: Mol Cell Biol. 2010 Jun;30(12):2983-95
references: 20404092
references: Cancer Cell. 2008 Mar;13(3):272-86
references: 18328430
references: Oncogene. 2001 Sep 10;20(40):5747-54
references: 11607824
references: Cell. 2008 Mar 7;132(5):875-86
references: 18329372
references: Cancer Res. 2010 Oct 15;70(20):8233-46
references: 20940405
references: Clin Cancer Res. 2011 Mar 15;17(6):1463-73
references: 21220470
references: Curr Opin Oncol. 2008 Jul;20(4):412-8
references: 18525337
references: PLoS One. 2011;6(8):e23205
references: 21826239
references: Cancer Res. 2012 Nov 15;72(22):5945-55
references: 22942255
references: Curr Pharm Des. 2008;14(11):1138-42
references: 18473860
references: Genes Dev. 2009 Dec 15;23(24):2839-49
references: 20008935
references: Blood. 2012 Feb 2;119(5):1162-72
references: 22096249
references: Cancer Cell. 2010 Jan 19;17(1):28-40
references: 20060366
references: J Pediatr Hematol Oncol. 2005 Oct;27(10):537-42
references: 16217257
references: Nucleic Acids Res. 2008 Sep;36(16):5391-404
references: 18701644
references: Oncogene. 2013 Mar 14;32(11):1441-51
references: 22641220
references: FEBS Lett. 2012 May 7;586(9):1279-86
references: 22465665
references: Sarcoma. 2011;2011:686985
references: 21052545
references: Nat Med. 2008 Nov;14(11):1271-7
references: 18931683
references: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references: 11309499
references: J Clin Oncol. 2010 Apr 20;28(12):1989-94
references: 20308669
references: Oncogene. 2011 May 5;30(18):2173-80
references: 21217773
references: Oncogene. 2013 Aug 15;32(33):3915-21
references: 22986530
references: PLoS One. 2011;6(8):e23592
references: 21853155
references: Cell Res. 2012 Mar;22(3):504-15
references: 21862971
references: Genes Dev. 2009 Dec 15;23(24):2806-11
references: 20008931
references: PLoS One. 2011;6(10):e26060
references: 22022506
references: Int J Biochem Cell Biol. 2010 Aug;42(8):1348-54
references: 20227518
references: Nat Methods. 2007 Sep;4(9):721-6
references: 17694064
references: Oncogene. 2010 Aug 12;29(32):4504-16
references: 20543858
references: Oncogene. 2011 Dec 8;30(49):4910-20
references: 21643012